India city Hyderabad covid-19 testing vaccine infection Updates India city Hyderabad

India's first COVID-19 vaccine Covaxin journey: From test results to phase 3 trial, latest updates

Reading now: 891
www.livemint.com

Covaxin, India's first COVID-19 vaccine candidate has sought the drug regulator's approval to start the large scale phase III clinical trial in the country.

The Drugs Controller General of India asked the vaccine maker Bharat Biotech to submit "complete safety and immunogenicity data of the phase II trial" and some clarifications before proceeding for the next stage.Developed by Bharat Biotech in collaboration with the Indian Council of Medical Research, Covaxin is currently in the phase II clinical trial in the country.

Hyderabad-based Bharat Biotech earlier released the animal study results of Covaxin. "The vaccine candidate was found to generate robust immune responses.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA